3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission

Details for Australian Patent Application No. 2006301432 (hide)

Owner NSAB, Filial af NeuroSearch Sweden AB, Sverige

Inventors Sonesson, Clas

Agent Davies Collison Cave

Pub. Number AU-B-2006301432

PCT Pub. Number WO2007/042295

Priority 0502254.6 13.10.05 SE

Filing date 12 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 15 December 2011

International Classifications

C07D 211/24 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/042295 Priority application(s): WO2007/042295

19 June 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read: 3,5-disubstituted phenylpiperidines as modulators of dopamine neurotransmission

9 October 2008 Assignment before Grant

  Neurosearch Sweden AB The application has been assigned to NSAB, Filial af NeuroSearch Sweden AB, Sverige

15 December 2011 Application Accepted

  Published as AU-B-2006301432

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301434-Structure with profiled surface for variable visual effects

2006301426-Nanobodies and polypeptides against EGFR and IGF-IR